{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-247379","form_type":"8-K","ticker":"IRON","cik":"0001816736","company_name":"Disc Medicine, Inc.","filed_at":"2023-09-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.395661+00:00","generated_at":"2026-06-10T07:01:59.957335+00:00","sec_items":["1.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Disc Medicine terminates at-the-market sales agreement with Leerink Partners","bullets":["Terminated the Sales Agreement dated January 25, 2023, effective September 28, 2023.","No termination penalties incurred; no shares sold under the agreement since June 12, 2023.","Company retains ability to seek alternative equity financing arrangements."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-247379","json":"https://secwatch.observer/filing/0001193125-23-247379.json","markdown":"https://secwatch.observer/filing/0001193125-23-247379.md","text":"https://secwatch.observer/filing/0001193125-23-247379.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1816736/000119312523247379/0001193125-23-247379-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1816736/000119312523247379/d856602d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T07:01:59.957335+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"dfec90d222907ba9663994a3d5ea3116a92c91c0","claim":"Disc Medicine, Inc. terminated Sales Agreement with Leerink Partners LLC (f/k/a SVB Securities LLC) valued at Termination of Sales Agreement without penalties (effective 2023-09-28).","evidence_excerpt":"On September 20, 2023, the Company delivered written notice to Leerink Partners LLC (f/k/a SVB Securities LLC) (\"Leerink\") that it was terminating the Sales Agreement dated January 25, 2023 (the \"Sales Agreement\"), by and between the Company and Leerink, in accordance with its terms, which termination became effective on September 28, 2023.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312523247379/0001193125-23-247379-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"termination"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"Leerink Partners LLC (f/k/a SVB Securities LLC)"},{"label":"Value","value":"Termination of Sales Agreement without penalties"},{"label":"Effective","value":"2023-09-28"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}